Skip to content

Drug interactions

Epcoritamab + Sirolimus

Severity: Moderate

Epcoritamab and Sirolimus: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Epcoritamab triggers cytokine release, which can transiently suppress CYP3A activity. Sirolimus exposure may increase, particularly around the step-up doses and during cytokine release syndrome.

What this interaction means in plain words

Epcoritamab and Sirolimus can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Epcoritamab belongs to Oncology; Sirolimus belongs to Miscellaneous.

Evidence level: Low

Why it happens

Cytokine-mediated suppression of CYP3A4 expression reduces sirolimus clearance.

What to do

Monitor sirolimus trough levels and toxicity during the first weeks of epcoritamab and during cytokine release syndrome; reduce the sirolimus dose if concentrations rise.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Epcoritamab and Sirolimus, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Epcoritamab with Sirolimus?

MediHelp rates the interaction as moderate. Epcoritamab and Sirolimus can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Epcoritamab triggers cytokine release, which can transiently suppress CYP3A activity. Sirolimus exposure may increase, particularly around the step-up doses and during cytokine release syndrome.

How serious is the interaction between Epcoritamab and Sirolimus?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor sirolimus trough levels and toxicity during the first weeks of epcoritamab and during cytokine release syndrome; reduce the sirolimus dose if concentrations rise.

What other medicines interact with Sirolimus?

MediHelp also lists interactions of Sirolimus with, for example, Adenovirus types 4 and 7 live, Bcg vaccine live, Influenza virus vaccine quadrivalent intranasal. The full list is on the Sirolimus page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in